← Back to All US Stocks

HLF Stock Analysis 2026 - HERBALIFE LTD. AI Rating

HLF NYSE Wholesale-Drugs, Proprietaries & Druggists' Sundries E9 CIK: 0001180262
Recently Updated • Analysis: Apr 11, 2026 • SEC Data: 2025-12-31
SELL
78% Conf
Pending
Analysis scheduled

📊 HLF Key Takeaways

Revenue: $5.0B
Net Margin: 4.5%
Free Cash Flow: $252.9M
Current Ratio: 1.13x
Debt/Equity: N/A
EPS: $2.20
AI Rating: SELL with 78% confidence

Is HLF a Good Investment? Thesis Analysis

Claude

Herbalife faces severe balance sheet distress with negative stockholders' equity of -$515.1M and excessive leverage ($2.0B debt vs. $353.1M cash), creating material financial risk despite positive operating cash flows. Stagnant revenue growth (+0.9%) and declining EPS (-12.0%) indicate deteriorating fundamental momentum, while weak liquidity ratios (Quick Ratio 0.62x) and thin interest coverage (2.2x) leave minimal cushion for operational disruption.

Why Buy HLF? Key Strengths

Claude
  • + Strong gross margins of 77.9% demonstrate pricing power and operational efficiency
  • + Positive operating cash flow of $333.3M and free cash flow of $252.9M provide near-term liquidity
  • + Established revenue base of $5.0B across global distribution network

HLF Investment Risks to Consider

Claude
  • ! Critical: Negative stockholders' equity of -$515.1M indicates insolvency on book basis and unsustainable capital structure
  • ! Excessive leverage: $2.0B long-term debt with only 2.2x interest coverage leaves minimal margin for error
  • ! Stagnant growth trajectory: Revenue growth of 0.9% YoY and flat net income (+0.2%) with declining EPS (-12.0%) suggest deteriorating business quality
  • ! Weak liquidity: Quick ratio of 0.62x and current ratio of 1.13x create vulnerability to cash flow disruptions
  • ! Multi-level marketing business model exposed to regulatory and reputational risks

Key Metrics to Watch

Claude
  • * Debt reduction and path to positive equity restoration
  • * Revenue growth acceleration above 5% YoY
  • * Interest coverage ratio improvement above 3.5x
  • * Quarterly operating cash flow sustainability and capital allocation decisions

HLF Financial Metrics

Revenue
$5.0B
Net Income
$228.3M
EPS (Diluted)
$2.20
Free Cash Flow
$252.9M
Total Assets
$2.8B
Cash Position
$353.1M

💡 AI Analyst Insight

HERBALIFE LTD. presents a mixed fundamental picture. Review the detailed metrics above to form your own investment thesis.

HLF Profitability Ratios

Gross Margin 77.9%
Operating Margin 9.5%
Net Margin 4.5%
ROE N/A
ROA 8.2%
FCF Margin 5.0%

HLF vs Default Sector

How HERBALIFE LTD. compares to Default sector averages

Net Margin
HLF 4.5%
vs
Sector Avg 12.0%
HLF Sector
ROE
HLF 0.0%
vs
Sector Avg 15.0%
HLF Sector
Current Ratio
HLF 1.1x
vs
Sector Avg 1.8x
HLF Sector
Debt/Equity
HLF 0.0x
vs
Sector Avg 0.7x
HLF Sector

Sector benchmarks are approximate industry averages. Actual sector performance may vary.

Is HLF Overvalued or Undervalued?

Based on fundamental analysis, HERBALIFE LTD. has mixed fundamental signals relative to the Default sector in 2026.

Return on Equity
N/A
Sector avg: 15%
Net Profit Margin
4.5%
Sector avg: 12%
Revenue Growth
N/A
Year-over-year
Debt/Equity
N/A
Sector avg: 0.7x

Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.

HLF Balance Sheet & Liquidity

Current Ratio
1.13x
Quick Ratio
0.62x
Debt/Equity
N/A
Debt/Assets
118.3%
Interest Coverage
2.24x
Long-term Debt
$2.0B

HLF 5-Year Financial Trend & Growth Analysis

HLF 5-year financial data: Year 2021: Revenue $5.8B, Net Income $311.0M, EPS $2.20. Year 2022: Revenue $5.8B, Net Income $372.6M, EPS $2.77. Year 2023: Revenue $5.8B, Net Income $447.2M, EPS $4.13. Year 2024: Revenue $5.2B, Net Income $321.3M, EPS $3.23. Year 2025: Revenue $5.1B, Net Income $142.2M, EPS $1.42.
Revenue
Net Income
EPS (right axis)

5-Year Trend Summary: HERBALIFE LTD.'s revenue has declined by 13% over the 5-year period, indicating business contraction. The most recent EPS of $1.42 reflects profitable operations.

HLF Growth Metrics (YoY)

Revenue Growth
N/A
Year-over-year
Net Income Growth
N/A
Year-over-year
EPS Growth
N/A
Earnings per share
FCF Margin
5.0%
Free cash flow / Revenue

HLF Quarterly Performance

Quarterly financial performance data for HERBALIFE LTD. including revenue, net income, and earnings per share.
Quarter Revenue Net Income EPS
Q3 2025 $1.2B $43.2M $0.42
Q2 2025 $1.3B $4.7M $0.05
Q1 2025 $1.2B $24.3M $0.24
Q3 2024 $1.2B $42.8M $0.43
Q2 2024 $1.3B $4.7M $0.05
Q1 2024 $1.3B $24.3M $0.24
Q3 2023 $1.3B $42.8M $0.43
Q2 2023 $1.3B $59.9M $0.60

Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.

HLF Capital Allocation

Operating Cash Flow
$333.3M
Cash generated from operations
Stock Buybacks
$8.2M
Shares repurchased (TTM)
Capital Expenditures
$80.4M
Investment in assets
Dividends
None
No dividend program

HLF SEC 10-K & 10-Q Filing Analysis

Access official SEC EDGAR filings for HERBALIFE LTD. (CIK: 0001180262)

📋 Recent SEC Filings

Date Form Document Action
Mar 17, 2026 DEF 14A ea0276754-01.htm View →
Feb 27, 2026 4 xslF345X05/ownership.xml View →
Feb 27, 2026 4 xslF345X05/ownership.xml View →
Feb 27, 2026 4 xslF345X05/ownership.xml View →
Feb 27, 2026 4 xslF345X05/ownership.xml View →

Frequently Asked Questions about HLF

What is the AI rating for HLF?

HERBALIFE LTD. (HLF) has an AI rating of SELL with 78% confidence, based on fundamental analysis of SEC EDGAR filings.

What are HLF's key strengths?

Claude: Strong gross margins of 77.9% demonstrate pricing power and operational efficiency. Positive operating cash flow of $333.3M and free cash flow of $252.9M provide near-term liquidity.

What are the risks of investing in HLF?

Claude: Critical: Negative stockholders' equity of -$515.1M indicates insolvency on book basis and unsustainable capital structure. Excessive leverage: $2.0B long-term debt with only 2.2x interest coverage leaves minimal margin for error.

What is HLF's revenue and growth?

HERBALIFE LTD. reported revenue of $5.0B.

Does HLF pay dividends?

HERBALIFE LTD. does not currently pay dividends.

Where can I find HLF SEC filings?

Official SEC filings for HERBALIFE LTD. (CIK: 0001180262) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.

What is HLF's EPS?

HERBALIFE LTD. has a diluted EPS of $2.20.

How is the AI analysis conducted?

Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.

Is HLF a good stock to buy right now?

Based on our AI fundamental analysis in April 2026, HERBALIFE LTD. has a SELL rating with 78% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.

Is HLF stock overvalued or undervalued?

Valuation metrics for HLF: ROE of N/A (sector avg: 15%), net margin of 4.5% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.

Should I buy HLF stock in 2026?

Our dual AI analysis gives HERBALIFE LTD. a combined SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.

What is HLF's free cash flow?

HERBALIFE LTD.'s operating cash flow is $333.3M, with capital expenditures of $80.4M. FCF margin is 5.0%.

How does HLF compare to other Default stocks?

Vs Default sector averages: Net margin 4.5% (avg: 12%), ROE N/A (avg: 15%), current ratio 1.13 (avg: 1.8).

Disclaimer: This analysis is generated by Claude AI (Anthropic) and ChatGPT (OpenAI) based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: Apr 11, 2026 | Data as of: 2025-12-31 | Powered by Claude AI